MS INFOGRAPHICS.pptx
•
1 j'aime•24 vues
Multiple sclerosis (MS) is a demyelinating disease that affects the central nervous system. Common symptoms include vertigo, fatigue, impaired speech, numbness, and vision loss. It is diagnosed based on symptoms, MRI/CT scans, and cerebrospinal fluid tests. There are several FDA-approved drugs to treat MS and manage relapses. Risk factors include genetic mutations and environmental exposures. MS primarily affects women and typically presents in young adults, with onset usually between ages 20-30. There is no cure, but treatments can help prevent relapses.
Signaler
Partager
Signaler
Partager
Recommandé
MOTOR NEURON DISEASE.pptx
Motor neuron diseases are a group of neurodegenerative disorders that progressively cause nerves in the brain and spinal cord to lose function, affecting voluntary muscle movement. The most common type in adults is amyotrophic lateral sclerosis (ALS), which affects both upper and lower motor neurons. There is no cure and treatments focus on managing symptoms and maximizing independence. Prognosis depends on the specific type of motor neuron disease and age of onset, with some forms being fatal and others non-fatal but still reducing quality of life over time.
Motor neuron disease
1. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive motor neuron disease that affects both upper and lower motor neurons.
2. ALS is defined by evidence of both lower motor neuron degeneration causing weakness, wasting, and fasciculations and upper motor neuron involvement shown by spasticity and increased reflexes.
3. Riluzole is the only FDA-approved drug shown to modestly slow disease progression in ALS patients, extending survival by a few months. Edaravone was also approved in 2017 as an antioxidant therapy.
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology is an open access, peer review Journal publishing original research & review articles on aetiology, epidemiology, and pathogenesis of inflammatory demyelinating diseases of the central nervous system. Austin Journal of Multiple Sclerosis & Neuroimmunology is aimed to provide a strong platform for challenging cases that includes but not excludes the damage of insulating covers of both central nervous system and spine. It is a grounding platform for all neurologists, neuroimmunologists, neurovirologists, researchers, medical doctors, health professionals, scientists, and scholars to publish their research work & update the latest research information.
Topics include but not limited to Clinical Neurology, Biomarkers, Glial, Myelin Chemistry, Neuroimaging, Neuropathology, Neuroepidemiology, Therapeutics, Genetics/Transcriptomics, Experimental Models, Pathobiology, Neuroimmunology, Neuropsychology, Neurorehabilitation, Pathobiology of the Brain, Psychology, Measurement Scales, Teaching, and Neuroethics.
Austin Journal of Multiple Sclerosis & Neuroimmunology supports the scientific transformation and fortification in Medical and Clinical research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology is an open access, peer review Journal publishing original research & review articles on aetiology, epidemiology, and pathogenesis of inflammatory demyelinating diseases of the central nervous system. Austin Journal of Multiple Sclerosis & Neuroimmunology is aimed to provide a strong platform for challenging cases that includes but not excludes the damage of insulating covers of both central nervous system and spine. It is a grounding platform for all neurologists, neuroimmunologists, neurovirologists, researchers, medical doctors, health professionals, scientists, and scholars to publish their research work & update the latest research information.
Topics include but not limited to Clinical Neurology, Biomarkers, Glial, Myelin Chemistry, Neuroimaging, Neuropathology, Neuroepidemiology, Therapeutics, Genetics/Transcriptomics, Experimental Models, Pathobiology, Neuroimmunology, Neuropsychology, Neurorehabilitation, Pathobiology of the Brain, Psychology, Measurement Scales, Teaching, and Neuroethics.
Austin Journal of Multiple Sclerosis & Neuroimmunology supports the scientific transformation and fortification in Medical and Clinical research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology is an open access, peer review Journal publishing original research & review articles on aetiology, epidemiology, and pathogenesis of inflammatory demyelinating diseases of the central nervous system. Austin Journal of Multiple Sclerosis & Neuroimmunology is aimed to provide a strong platform for challenging cases that includes but not excludes the damage of insulating covers of both central nervous system and spine. It is a grounding platform for all neurologists, neuroimmunologists, neurovirologists, researchers, medical doctors, health professionals, scientists, and scholars to publish their research work & update the latest research information.
Topics include but not limited to Clinical Neurology, Biomarkers, Glial, Myelin Chemistry, Neuroimaging, Neuropathology, Neuroepidemiology, Therapeutics, Genetics/Transcriptomics, Experimental Models, Pathobiology, Neuroimmunology, Neuropsychology, Neurorehabilitation, Pathobiology of the Brain, Psychology, Measurement Scales, Teaching, and Neuroethics.
Austin Journal of Multiple Sclerosis & Neuroimmunology supports the scientific transformation and fortification in Medical and Clinical research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Austin Journal of Clinical Immunology
Austin Journal of Clinical Immunology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of immunology, asthma and allergy. The aim of the journal is to develop a knowledge sharing platform and an interactive network for immunologists, researchers, physicians, and other health professionals for exchange of scientific information in the areas of immunology.
Austin Journal of Clinical Immunology accepts original research articles, review articles, case reports, clinical images and rapid communication on all the aspects of immunology and immunotechnology.
Austin Journal of Clinical Immunology strongly supports the scientific upgradation and fortification in related scientific research community by enhancing access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed journals under one roof thereby promoting knowledge sharing, mutual promotion of multidisciplinary science.
Austin Journal of Clinical Immunology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of immunology, asthma and allergy.
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology is an open access, peer review Journal publishing original research & review articles on aetiology, epidemiology, and pathogenesis of inflammatory demyelinating diseases of the central nervous system. Austin Journal of Multiple Sclerosis & Neuroimmunology is aimed to provide a strong platform for challenging cases that includes but not excludes the damage of insulating covers of both central nervous system and spine. It is a grounding platform for all neurologists, neuroimmunologists, neurovirologists, researchers, medical doctors, health professionals, scientists, and scholars to publish their research work & update the latest research information.
Topics include but not limited to Clinical Neurology, Biomarkers, Glial, Myelin Chemistry, Neuroimaging, Neuropathology, Neuroepidemiology, Therapeutics, Genetics/Transcriptomics, Experimental Models, Pathobiology, Neuroimmunology, Neuropsychology, Neurorehabilitation, Pathobiology of the Brain, Psychology, Measurement Scales, Teaching, and Neuroethics.
Austin Journal of Multiple Sclerosis & Neuroimmunology supports the scientific transformation and fortification in Medical and Clinical research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Motor neuron diseases. ppt.
Motor neuron diseases are a group of neurodegenerative disorders that affect motor neurons in the brain and spinal cord, leading to progressive muscle weakness. The most common type is amyotrophic lateral sclerosis (ALS), which affects both upper and lower motor neurons. Symptoms start in one area, such as weakness in the arms or slurred speech, and gradually spread. As motor neurons die, muscles waste away and it becomes difficult to move, swallow, breathe and speak. There is no cure and the cause is largely unknown, though some risk factors include age, sex, family history and head trauma. Treatment focuses on managing symptoms and maximizing function and comfort through supportive care, devices, therapy and medications like riluzole.
Recommandé
MOTOR NEURON DISEASE.pptx
Motor neuron diseases are a group of neurodegenerative disorders that progressively cause nerves in the brain and spinal cord to lose function, affecting voluntary muscle movement. The most common type in adults is amyotrophic lateral sclerosis (ALS), which affects both upper and lower motor neurons. There is no cure and treatments focus on managing symptoms and maximizing independence. Prognosis depends on the specific type of motor neuron disease and age of onset, with some forms being fatal and others non-fatal but still reducing quality of life over time.
Motor neuron disease
1. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive motor neuron disease that affects both upper and lower motor neurons.
2. ALS is defined by evidence of both lower motor neuron degeneration causing weakness, wasting, and fasciculations and upper motor neuron involvement shown by spasticity and increased reflexes.
3. Riluzole is the only FDA-approved drug shown to modestly slow disease progression in ALS patients, extending survival by a few months. Edaravone was also approved in 2017 as an antioxidant therapy.
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology is an open access, peer review Journal publishing original research & review articles on aetiology, epidemiology, and pathogenesis of inflammatory demyelinating diseases of the central nervous system. Austin Journal of Multiple Sclerosis & Neuroimmunology is aimed to provide a strong platform for challenging cases that includes but not excludes the damage of insulating covers of both central nervous system and spine. It is a grounding platform for all neurologists, neuroimmunologists, neurovirologists, researchers, medical doctors, health professionals, scientists, and scholars to publish their research work & update the latest research information.
Topics include but not limited to Clinical Neurology, Biomarkers, Glial, Myelin Chemistry, Neuroimaging, Neuropathology, Neuroepidemiology, Therapeutics, Genetics/Transcriptomics, Experimental Models, Pathobiology, Neuroimmunology, Neuropsychology, Neurorehabilitation, Pathobiology of the Brain, Psychology, Measurement Scales, Teaching, and Neuroethics.
Austin Journal of Multiple Sclerosis & Neuroimmunology supports the scientific transformation and fortification in Medical and Clinical research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology is an open access, peer review Journal publishing original research & review articles on aetiology, epidemiology, and pathogenesis of inflammatory demyelinating diseases of the central nervous system. Austin Journal of Multiple Sclerosis & Neuroimmunology is aimed to provide a strong platform for challenging cases that includes but not excludes the damage of insulating covers of both central nervous system and spine. It is a grounding platform for all neurologists, neuroimmunologists, neurovirologists, researchers, medical doctors, health professionals, scientists, and scholars to publish their research work & update the latest research information.
Topics include but not limited to Clinical Neurology, Biomarkers, Glial, Myelin Chemistry, Neuroimaging, Neuropathology, Neuroepidemiology, Therapeutics, Genetics/Transcriptomics, Experimental Models, Pathobiology, Neuroimmunology, Neuropsychology, Neurorehabilitation, Pathobiology of the Brain, Psychology, Measurement Scales, Teaching, and Neuroethics.
Austin Journal of Multiple Sclerosis & Neuroimmunology supports the scientific transformation and fortification in Medical and Clinical research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology is an open access, peer review Journal publishing original research & review articles on aetiology, epidemiology, and pathogenesis of inflammatory demyelinating diseases of the central nervous system. Austin Journal of Multiple Sclerosis & Neuroimmunology is aimed to provide a strong platform for challenging cases that includes but not excludes the damage of insulating covers of both central nervous system and spine. It is a grounding platform for all neurologists, neuroimmunologists, neurovirologists, researchers, medical doctors, health professionals, scientists, and scholars to publish their research work & update the latest research information.
Topics include but not limited to Clinical Neurology, Biomarkers, Glial, Myelin Chemistry, Neuroimaging, Neuropathology, Neuroepidemiology, Therapeutics, Genetics/Transcriptomics, Experimental Models, Pathobiology, Neuroimmunology, Neuropsychology, Neurorehabilitation, Pathobiology of the Brain, Psychology, Measurement Scales, Teaching, and Neuroethics.
Austin Journal of Multiple Sclerosis & Neuroimmunology supports the scientific transformation and fortification in Medical and Clinical research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Austin Journal of Clinical Immunology
Austin Journal of Clinical Immunology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of immunology, asthma and allergy. The aim of the journal is to develop a knowledge sharing platform and an interactive network for immunologists, researchers, physicians, and other health professionals for exchange of scientific information in the areas of immunology.
Austin Journal of Clinical Immunology accepts original research articles, review articles, case reports, clinical images and rapid communication on all the aspects of immunology and immunotechnology.
Austin Journal of Clinical Immunology strongly supports the scientific upgradation and fortification in related scientific research community by enhancing access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed journals under one roof thereby promoting knowledge sharing, mutual promotion of multidisciplinary science.
Austin Journal of Clinical Immunology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of immunology, asthma and allergy.
Austin Journal of Multiple Sclerosis & Neuroimmunology
Austin Journal of Multiple Sclerosis & Neuroimmunology is an open access, peer review Journal publishing original research & review articles on aetiology, epidemiology, and pathogenesis of inflammatory demyelinating diseases of the central nervous system. Austin Journal of Multiple Sclerosis & Neuroimmunology is aimed to provide a strong platform for challenging cases that includes but not excludes the damage of insulating covers of both central nervous system and spine. It is a grounding platform for all neurologists, neuroimmunologists, neurovirologists, researchers, medical doctors, health professionals, scientists, and scholars to publish their research work & update the latest research information.
Topics include but not limited to Clinical Neurology, Biomarkers, Glial, Myelin Chemistry, Neuroimaging, Neuropathology, Neuroepidemiology, Therapeutics, Genetics/Transcriptomics, Experimental Models, Pathobiology, Neuroimmunology, Neuropsychology, Neurorehabilitation, Pathobiology of the Brain, Psychology, Measurement Scales, Teaching, and Neuroethics.
Austin Journal of Multiple Sclerosis & Neuroimmunology supports the scientific transformation and fortification in Medical and Clinical research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Motor neuron diseases. ppt.
Motor neuron diseases are a group of neurodegenerative disorders that affect motor neurons in the brain and spinal cord, leading to progressive muscle weakness. The most common type is amyotrophic lateral sclerosis (ALS), which affects both upper and lower motor neurons. Symptoms start in one area, such as weakness in the arms or slurred speech, and gradually spread. As motor neurons die, muscles waste away and it becomes difficult to move, swallow, breathe and speak. There is no cure and the cause is largely unknown, though some risk factors include age, sex, family history and head trauma. Treatment focuses on managing symptoms and maximizing function and comfort through supportive care, devices, therapy and medications like riluzole.
Motor neuron disease.pptx new
Motor neuron diseases are a group of rare neurodegenerative disorders that progressively cause nerves in the brain and spinal cord to lose function, affecting voluntary muscle movement. The most common type in adults is amyotrophic lateral sclerosis (ALS), which affects both upper and lower motor neurons. There is no cure for motor neuron diseases, so treatment focuses on managing symptoms and maximizing quality of life through supportive care, rehabilitation, and FDA-approved drugs that may slow progression. Prognosis depends on the specific type of motor neuron disease and age of onset, with some forms being fatal and others non-fatal but still impacting quality of life over time.
multiple sclerosis
This document provides an overview of demyelinating diseases of the central nervous system, with a focus on multiple sclerosis. It discusses the etiology, pathogenesis, clinical features, diagnosis, treatment and management of multiple sclerosis. Key points include: MS results from an autoimmune attack on the myelin sheath surrounding nerves in the brain and spinal cord; diagnosis involves evidence of lesions disseminated in space and time via MRI or other tests; and treatments include steroids for acute attacks and disease-modifying drugs such as interferons to reduce relapse rates long-term.
Motor neuron disease
Motor neuron disease (MND) refers to conditions characterized by degeneration of upper and lower motor neurons. Amyotrophic lateral sclerosis (ALS) is the most common form of MND and involves both upper and lower motor neurons. ALS is clinically defined based on involvement of motor neurons and includes features such as muscle weakness, atrophy, fasciculations, and stiffness. The pathology of ALS involves degeneration and death of motor neurons in the brain, brainstem, and spinal cord leading to muscle denervation and atrophy. While the cause of ALS is largely unknown, factors such as oxidative stress, protein aggregation, mitochondrial dysfunction, and glutamate excitotoxicity are hypothesized to contribute to motor neuron de
Multiple sclerosis
This document provides an overview of multiple sclerosis (MS). It begins by defining MS as a disease of the central nervous system involving destruction of myelin. It then discusses who is most likely to get MS, noting it occurs most often in Caucasians between ages 20-50 and more frequently in women than men. The document explains that in MS the immune system mistakenly attacks myelin. It describes the different types of MS and common symptoms. Diagnosis involves MRI, neurological tests, and spinal fluid examination. Treatment aims to reduce inflammation and immune system activity. The role of the immune system and proteins like GM-CSF and perforin in the development and progression of MS lesions is also summarized.
SIN04 - Treatment of Depression In Neurological Disease An Evidence Based A...
Depression is common in many neurological and medical conditions. It can influence outcomes and prognosis. Treatment requires consideration of issues specific to each condition such as effects on symptoms, cognition, rehabilitation, and mortality. While evidence is limited, antidepressants may benefit conditions like stroke, Parkinson's disease, and multiple sclerosis when used carefully. Future research needs to further evaluate treatments and their impact on overall physical health and quality of life outcomes.
Multiple sclerosis: Introduction, Risk Factors, Diagnosis and Treatment
Introduction about Multiple Sclerosis.
Risk factors affect to Multiple Sclerosis.
When to Suspect Multiple Sclerosis.
Evaluation and Diagnosis of Multiple Sclerosis.
How to treatment of Multiple Sclerosis.
Treatment of Multiple Sclerosis with Monoclonal Antibody.
Multiple sclerosis
Multiple sclerosis (MS) is a demyelinating disease of central nervous system which includes brain and spinal cord.
it affect the myelin and by damaging the the myelin producing cell -Oligodendrocytes, which leads to sensory, motor and cognitive problems.
Dementia-final
Dementia is a progressive deterioration of intellect, behavior and personality caused by diseases of the brain. The most common causes are Alzheimer's disease (~60% of cases) and cerebrovascular disease (~20% of cases). Dementia is not a single disease but an overall term for loss of brain function. Treatment depends on the underlying cause but currently available medications can only temporarily improve symptoms and do not cure or slow progression. Lifestyle factors may help reduce risk of conditions that can lead to dementia like stroke.
Dementia
Dementia is a progressive deterioration of intellect, behavior and personality caused by diseases of the brain. The most common causes are Alzheimer's disease (~60% of cases) and cerebrovascular disease (~20% of cases). Dementia is not a single disease but an overall term for loss of brain function. Treatment depends on the underlying cause but currently available medications can only temporarily improve symptoms and do not cure or slow progression. Lifestyle factors may help reduce risk of conditions that can lead to dementia like stroke.
multiplesclerosis-171219042211.pdf
Multiple sclerosis (MS) is a neurodegenerative disease that affects the central nervous system through inflammation and demyelination. It is more common in women than men and typically occurs in young adults between 20-40 years old. MS is predominantly found in northern regions of the world. While its cause is unknown, genetic and environmental factors like infections are thought to play a role. Symptoms vary depending on the areas of the nervous system affected but can include vision problems, impaired movement, sensory issues, and mental changes. MS is diagnosed based on symptoms and examinations and has varying degrees of severity.
Multiple sclerosis
Multiple sclerosis (MS) is a neurodegenerative disease that affects the central nervous system through inflammation and demyelination. It is more common in women than men and typically occurs in young adults between 20-40 years old. MS is predominantly found in northern regions of the world. While its cause is unknown, genetic and environmental factors like infections are thought to play a role. Symptoms vary depending on the areas of the nervous system affected but can include vision problems, impaired movement, sensory issues, and mental changes. The disease progresses over time and treatment aims to manage symptoms and reduce inflammation.
6 multiple sclerosis nero medicine
This document provides information about Multiple Sclerosis (MS). It defines MS as a chronic neurological disorder that affects the central nervous system, where myelin is destroyed in the brain and spinal cord, causing scarring in multiple sites. MS is the most common disabling condition in young adults. While its cause is unknown, it involves an immunological reaction destroying myelin. Symptoms vary between patients and can include vision changes, numbness, weakness, and problems with coordination or bladder control. Diagnosis involves MRI imaging and other tests. Currently, there is no cure for MS but treatments can help reduce symptoms and slow progression.
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
This document discusses idiopathic inflammatory myopathies (IIMs), including polymyositis, dermatomyositis, and inclusion body myositis. It reviews the clinical features, diagnostic criteria, pathology, and treatment strategies for these conditions. It also presents a case of a patient presenting with proximal muscle weakness who is diagnosed with polymyositis based on elevated CK, myopathic EMG findings, and muscle biopsy consistent with polymyositis. Treatment options discussed for IIMs include corticosteroids, immunosuppressants, rituximab, and intravenous immunoglobulin.
Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a rare neurological disease that primarily affects the nerve cells (neurons) responsible for controlling voluntary muscle movement (those muscles we choose to move). Voluntary muscles produce movements like chewing, walking, and talking.
Multiple Sclerosis (MS)
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system where the body's immune system attacks the protective myelin sheath surrounding the nerves. It most commonly affects people between 20-40 years of age. While the exact cause is unknown, genetic and environmental factors are thought to play a role. The four main types are relapsing-remitting MS, primary-progressive MS, progressive-relapsing MS, and secondary-progressive MS. Symptoms vary depending on the affected areas of the brain and spinal cord but may include vision issues, weakness, numbness, and problems with coordination and balance. Diagnosis involves neurological exams, MRI scans and analysis of cerebrospinal fluid
Multiple sclerosis
This powerpoint presentation summarizes key information about multiple sclerosis (MS), including what it is, common symptoms, potential causes, how it affects the nervous system, current treatments, history of the disease, who is most likely to be affected, and life expectancy. MS is an unpredictable neurological disorder that disrupts communication between the brain and body, and can cause fatigue, mobility issues, vision problems, and other symptoms. While there is no known cause, genetics and environmental factors likely play a role. It primarily affects adults aged 20-50 and is more common in those of northern European descent. Treatments aim to modify symptoms and slow progression, but there is currently no cure.
Multiple sclerosis-1.pptx
Multiple sclerosis is a disease where the immune system attacks the myelin sheath surrounding nerves. This damages communication between the brain and body and can eventually damage nerves themselves. Symptoms vary depending on location of damage and affected nerves, and include numbness, vision problems, tingling, fatigue, and more. Most people experience relapses followed by remissions. Eventually, about 60-70% develop steady progression of symptoms. The cause is unknown but is believed to be autoimmune, and risk factors include age, sex, family history, and certain infections. Diagnosis involves ruling out other conditions and may include MRI, spinal tap, and blood tests showing abnormalities associated with MS. Treatment focuses on reducing inflammation with steroids or plasma
Multiple Sclerosis And The Central Nervous System
Multiple sclerosis is an autoimmune disease that affects the central nervous system, including the brain and spinal cord. It causes damage to the myelin sheath that surrounds nerve fibers, which can impair nerve signals. There is currently no cure for MS, but treatments can help suppress symptoms and slow progression. The disease is characterized by different types defined by periods of relapse and remission. Neurons transmit signals throughout the body, and damage from MS can disrupt these signals and cause issues like fatigue, vision problems, and mobility issues.
MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is a disease affecting nerves in the brain and spinal cord, causing problems with muscle movement, balance and vision
1.multiple sclerosis
This document discusses myelin, its composition and function. It describes how myelin forms a sheath around neurons, insulating them and allowing rapid nerve impulse propagation. Cholesterol and proteins like myelin basic protein are important myelin components. Myelination begins in fetal development and continues through life. Diseases like multiple sclerosis involve demyelination through autoimmune or other processes. The document examines MS in terms of epidemiology, pathogenesis, clinical presentation and investigations like CSF analysis and MRI that are used in diagnosis.
Reverse Pharmacology.pptx
Reverse pharmacology is an approach to drug discovery that begins with biological molecules found in nature and works "backward" to determine their mechanism of action and potential therapeutic effects, rather than starting with a disease target. This allows the discovery of potentially useful compounds from traditional medicines and natural sources that may otherwise be overlooked. The approach involves three experimental phases - experiential, exploratory, and experimental - moving from human to animal studies to determine a molecule's effects in the body. Many important drugs have been discovered through reverse pharmacology by investigating the active compounds in plants, microbes, and other natural sources.
Impact factor.pptx
The document discusses the impact factor, which is a bibliometric measure that reflects how frequently an average article in a journal is cited over a two year period. It is widely used to evaluate research quality and influence journal rankings, but it also has limitations and criticisms. Specifically, the impact factor can be manipulated, does not assess individual articles, and may not be applicable to all fields. The document also introduces some alternative metrics like altmetrics and h-index that aim to provide more well-rounded assessments of research.
Contenu connexe
Similaire à MS INFOGRAPHICS.pptx
Motor neuron disease.pptx new
Motor neuron diseases are a group of rare neurodegenerative disorders that progressively cause nerves in the brain and spinal cord to lose function, affecting voluntary muscle movement. The most common type in adults is amyotrophic lateral sclerosis (ALS), which affects both upper and lower motor neurons. There is no cure for motor neuron diseases, so treatment focuses on managing symptoms and maximizing quality of life through supportive care, rehabilitation, and FDA-approved drugs that may slow progression. Prognosis depends on the specific type of motor neuron disease and age of onset, with some forms being fatal and others non-fatal but still impacting quality of life over time.
multiple sclerosis
This document provides an overview of demyelinating diseases of the central nervous system, with a focus on multiple sclerosis. It discusses the etiology, pathogenesis, clinical features, diagnosis, treatment and management of multiple sclerosis. Key points include: MS results from an autoimmune attack on the myelin sheath surrounding nerves in the brain and spinal cord; diagnosis involves evidence of lesions disseminated in space and time via MRI or other tests; and treatments include steroids for acute attacks and disease-modifying drugs such as interferons to reduce relapse rates long-term.
Motor neuron disease
Motor neuron disease (MND) refers to conditions characterized by degeneration of upper and lower motor neurons. Amyotrophic lateral sclerosis (ALS) is the most common form of MND and involves both upper and lower motor neurons. ALS is clinically defined based on involvement of motor neurons and includes features such as muscle weakness, atrophy, fasciculations, and stiffness. The pathology of ALS involves degeneration and death of motor neurons in the brain, brainstem, and spinal cord leading to muscle denervation and atrophy. While the cause of ALS is largely unknown, factors such as oxidative stress, protein aggregation, mitochondrial dysfunction, and glutamate excitotoxicity are hypothesized to contribute to motor neuron de
Multiple sclerosis
This document provides an overview of multiple sclerosis (MS). It begins by defining MS as a disease of the central nervous system involving destruction of myelin. It then discusses who is most likely to get MS, noting it occurs most often in Caucasians between ages 20-50 and more frequently in women than men. The document explains that in MS the immune system mistakenly attacks myelin. It describes the different types of MS and common symptoms. Diagnosis involves MRI, neurological tests, and spinal fluid examination. Treatment aims to reduce inflammation and immune system activity. The role of the immune system and proteins like GM-CSF and perforin in the development and progression of MS lesions is also summarized.
SIN04 - Treatment of Depression In Neurological Disease An Evidence Based A...
Depression is common in many neurological and medical conditions. It can influence outcomes and prognosis. Treatment requires consideration of issues specific to each condition such as effects on symptoms, cognition, rehabilitation, and mortality. While evidence is limited, antidepressants may benefit conditions like stroke, Parkinson's disease, and multiple sclerosis when used carefully. Future research needs to further evaluate treatments and their impact on overall physical health and quality of life outcomes.
Multiple sclerosis: Introduction, Risk Factors, Diagnosis and Treatment
Introduction about Multiple Sclerosis.
Risk factors affect to Multiple Sclerosis.
When to Suspect Multiple Sclerosis.
Evaluation and Diagnosis of Multiple Sclerosis.
How to treatment of Multiple Sclerosis.
Treatment of Multiple Sclerosis with Monoclonal Antibody.
Multiple sclerosis
Multiple sclerosis (MS) is a demyelinating disease of central nervous system which includes brain and spinal cord.
it affect the myelin and by damaging the the myelin producing cell -Oligodendrocytes, which leads to sensory, motor and cognitive problems.
Dementia-final
Dementia is a progressive deterioration of intellect, behavior and personality caused by diseases of the brain. The most common causes are Alzheimer's disease (~60% of cases) and cerebrovascular disease (~20% of cases). Dementia is not a single disease but an overall term for loss of brain function. Treatment depends on the underlying cause but currently available medications can only temporarily improve symptoms and do not cure or slow progression. Lifestyle factors may help reduce risk of conditions that can lead to dementia like stroke.
Dementia
Dementia is a progressive deterioration of intellect, behavior and personality caused by diseases of the brain. The most common causes are Alzheimer's disease (~60% of cases) and cerebrovascular disease (~20% of cases). Dementia is not a single disease but an overall term for loss of brain function. Treatment depends on the underlying cause but currently available medications can only temporarily improve symptoms and do not cure or slow progression. Lifestyle factors may help reduce risk of conditions that can lead to dementia like stroke.
multiplesclerosis-171219042211.pdf
Multiple sclerosis (MS) is a neurodegenerative disease that affects the central nervous system through inflammation and demyelination. It is more common in women than men and typically occurs in young adults between 20-40 years old. MS is predominantly found in northern regions of the world. While its cause is unknown, genetic and environmental factors like infections are thought to play a role. Symptoms vary depending on the areas of the nervous system affected but can include vision problems, impaired movement, sensory issues, and mental changes. MS is diagnosed based on symptoms and examinations and has varying degrees of severity.
Multiple sclerosis
Multiple sclerosis (MS) is a neurodegenerative disease that affects the central nervous system through inflammation and demyelination. It is more common in women than men and typically occurs in young adults between 20-40 years old. MS is predominantly found in northern regions of the world. While its cause is unknown, genetic and environmental factors like infections are thought to play a role. Symptoms vary depending on the areas of the nervous system affected but can include vision problems, impaired movement, sensory issues, and mental changes. The disease progresses over time and treatment aims to manage symptoms and reduce inflammation.
6 multiple sclerosis nero medicine
This document provides information about Multiple Sclerosis (MS). It defines MS as a chronic neurological disorder that affects the central nervous system, where myelin is destroyed in the brain and spinal cord, causing scarring in multiple sites. MS is the most common disabling condition in young adults. While its cause is unknown, it involves an immunological reaction destroying myelin. Symptoms vary between patients and can include vision changes, numbness, weakness, and problems with coordination or bladder control. Diagnosis involves MRI imaging and other tests. Currently, there is no cure for MS but treatments can help reduce symptoms and slow progression.
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
This document discusses idiopathic inflammatory myopathies (IIMs), including polymyositis, dermatomyositis, and inclusion body myositis. It reviews the clinical features, diagnostic criteria, pathology, and treatment strategies for these conditions. It also presents a case of a patient presenting with proximal muscle weakness who is diagnosed with polymyositis based on elevated CK, myopathic EMG findings, and muscle biopsy consistent with polymyositis. Treatment options discussed for IIMs include corticosteroids, immunosuppressants, rituximab, and intravenous immunoglobulin.
Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a rare neurological disease that primarily affects the nerve cells (neurons) responsible for controlling voluntary muscle movement (those muscles we choose to move). Voluntary muscles produce movements like chewing, walking, and talking.
Multiple Sclerosis (MS)
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system where the body's immune system attacks the protective myelin sheath surrounding the nerves. It most commonly affects people between 20-40 years of age. While the exact cause is unknown, genetic and environmental factors are thought to play a role. The four main types are relapsing-remitting MS, primary-progressive MS, progressive-relapsing MS, and secondary-progressive MS. Symptoms vary depending on the affected areas of the brain and spinal cord but may include vision issues, weakness, numbness, and problems with coordination and balance. Diagnosis involves neurological exams, MRI scans and analysis of cerebrospinal fluid
Multiple sclerosis
This powerpoint presentation summarizes key information about multiple sclerosis (MS), including what it is, common symptoms, potential causes, how it affects the nervous system, current treatments, history of the disease, who is most likely to be affected, and life expectancy. MS is an unpredictable neurological disorder that disrupts communication between the brain and body, and can cause fatigue, mobility issues, vision problems, and other symptoms. While there is no known cause, genetics and environmental factors likely play a role. It primarily affects adults aged 20-50 and is more common in those of northern European descent. Treatments aim to modify symptoms and slow progression, but there is currently no cure.
Multiple sclerosis-1.pptx
Multiple sclerosis is a disease where the immune system attacks the myelin sheath surrounding nerves. This damages communication between the brain and body and can eventually damage nerves themselves. Symptoms vary depending on location of damage and affected nerves, and include numbness, vision problems, tingling, fatigue, and more. Most people experience relapses followed by remissions. Eventually, about 60-70% develop steady progression of symptoms. The cause is unknown but is believed to be autoimmune, and risk factors include age, sex, family history, and certain infections. Diagnosis involves ruling out other conditions and may include MRI, spinal tap, and blood tests showing abnormalities associated with MS. Treatment focuses on reducing inflammation with steroids or plasma
Multiple Sclerosis And The Central Nervous System
Multiple sclerosis is an autoimmune disease that affects the central nervous system, including the brain and spinal cord. It causes damage to the myelin sheath that surrounds nerve fibers, which can impair nerve signals. There is currently no cure for MS, but treatments can help suppress symptoms and slow progression. The disease is characterized by different types defined by periods of relapse and remission. Neurons transmit signals throughout the body, and damage from MS can disrupt these signals and cause issues like fatigue, vision problems, and mobility issues.
MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is a disease affecting nerves in the brain and spinal cord, causing problems with muscle movement, balance and vision
1.multiple sclerosis
This document discusses myelin, its composition and function. It describes how myelin forms a sheath around neurons, insulating them and allowing rapid nerve impulse propagation. Cholesterol and proteins like myelin basic protein are important myelin components. Myelination begins in fetal development and continues through life. Diseases like multiple sclerosis involve demyelination through autoimmune or other processes. The document examines MS in terms of epidemiology, pathogenesis, clinical presentation and investigations like CSF analysis and MRI that are used in diagnosis.
Similaire à MS INFOGRAPHICS.pptx (20)
SIN04 - Treatment of Depression In Neurological Disease An Evidence Based A...
SIN04 - Treatment of Depression In Neurological Disease An Evidence Based A...
Multiple sclerosis: Introduction, Risk Factors, Diagnosis and Treatment
Multiple sclerosis: Introduction, Risk Factors, Diagnosis and Treatment
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
Plus de Pranavi Uppuluri
Reverse Pharmacology.pptx
Reverse pharmacology is an approach to drug discovery that begins with biological molecules found in nature and works "backward" to determine their mechanism of action and potential therapeutic effects, rather than starting with a disease target. This allows the discovery of potentially useful compounds from traditional medicines and natural sources that may otherwise be overlooked. The approach involves three experimental phases - experiential, exploratory, and experimental - moving from human to animal studies to determine a molecule's effects in the body. Many important drugs have been discovered through reverse pharmacology by investigating the active compounds in plants, microbes, and other natural sources.
Impact factor.pptx
The document discusses the impact factor, which is a bibliometric measure that reflects how frequently an average article in a journal is cited over a two year period. It is widely used to evaluate research quality and influence journal rankings, but it also has limitations and criticisms. Specifically, the impact factor can be manipulated, does not assess individual articles, and may not be applicable to all fields. The document also introduces some alternative metrics like altmetrics and h-index that aim to provide more well-rounded assessments of research.
CADD Presentation by Pranavi.pptx
Computer aided drug design (CADD) uses computational tools to aid in the drug discovery and development process. It relies on digital repositories to study how potential drug compounds may interact with biological targets. CADD methods can screen thousands of compounds simultaneously, increase the odds of identifying compounds with desired characteristics, and help speed up the drug development process from hit to lead. Some key applications of CADD include lead discovery and optimization, predicting ligand-target interactions, and assessing drug-like properties of compounds.
The Role of ADME ^0 Toxicology Studies S.pptx
This document discusses the role of in silico ADME & toxicology studies in drug discovery and development. It explains that ADMET refers to absorption, distribution, metabolism, excretion and toxicity studies, which help determine a drug candidate's viability by answering questions about how the body handles the drug. In silico methods are needed for cost-efficiency, early decision making and compliance. A variety of computational tools can predict important ADME properties like half-life and clearance. These studies are important at various stages from early discovery to post-market surveillance. No single approach provides all ADME data, so a combination of methods is often used.
hepatitis day post.pptx
Hepatitis is a disease that causes inflammation of the liver and is caused by several different viruses and other factors. There are five main types of viral hepatitis: A, B, C, D, and E. Hepatitis A and E are primarily spread through contaminated food and water, while hepatitis B, C, and D are spread through blood and bodily fluids. Hepatitis is a major global health concern, affecting millions worldwide, with the highest burden in low and middle income countries where access to testing and treatment is limited.
MOLECULAR DOCKING IN DRUG DESIGN AND DEVELOPMENT BY PRANAVI linkedin.pptx
This document discusses molecular docking, which is a technique used in bioinformatics and drug design to predict how biological molecules, like proteins and ligands, bind to each other. It begins by defining bioinformatics and explaining why molecular docking is important for applications like drug design and signal transduction. The document then discusses key concepts in molecular docking like rigid and flexible docking, different docking software tools, and challenges associated with molecular docking.
Big data in precision medicine.pptx
This document discusses how big data and precision medicine are used together. It begins by defining big data and precision medicine. It then describes how machine learning tools analyze big data to provide insights. Examples are given of how precision medicine uses biomarkers to target treatments for various cancers and other diseases. The integration of big data into precision medicine is explained, from data collection and analysis to individualized treatment.
sbdd lbdd fbdd.pptx
The document compares three protein structure prediction methods: homology modeling, threading/fold recognition, and ab initio modeling. Homology modeling relies on templates and is most accurate when closely related structures exist, while ab initio modeling predicts structure from sequence alone without templates and is least accurate. Threading falls between the two, utilizing structural databases but not exclusively, with moderate success rates and accuracy depending on algorithm and template quality.
Unraveling-Zoonotic-Diseases-on-World-Zoonoses-Day-2023.pptx
This document discusses zoonotic diseases, which transmit from animals to humans, on World Zoonoses Day 2023. It covers the historical context of zoonotic disease discovery, examples of major zoonotic diseases, their causes/symptoms/treatments, prevention and management strategies, and the future of research. The One Health approach of medical, veterinary and environmental collaboration is emphasized as key to controlling zoonotic diseases for a healthier future.
brain tumor info.pdf
Brain tumors can cause various signs and symptoms like personality changes, confusion, vomiting, nausea, prolonged fatigue, seizures, impaired vision, bad speech and hearing, and progressive headaches. They are the leading cause of solid cancer death in children under 20. Some common types include gliomas, choroid plexus tumors, embryonal tumors, germ cell tumors, pineal tumors, and meningiomas. Risk factors include inherited conditions, age, chemical exposure, radiation, and metastasis from other cancers. Diagnosis involves a neurological examination, head CT scan, brain MRI, and PET scan of the brain.
InsilicoPCR.pptx
This document discusses in silico PCR, which is a computational technique for simulating PCR reactions without physically performing experiments in a lab. It allows researchers to predict amplicon size and location, and assess primer specificity. The key benefits of in silico PCR include cost-efficiency, time savings, experimental design assistance, and quality control. The document provides details on the protocol for conducting in silico PCR using various bioinformatics tools. It also outlines some common applications of PCR such as DNA amplification, molecular cloning, and gene expression analysis.
COPD.pptx
This document discusses chronic obstructive pulmonary disease (COPD). It begins by defining COPD as a progressive lung disease caused by conditions like chronic bronchitis and emphysema. It then covers risk factors for COPD like smoking, occupational exposures, and genetic factors. The document outlines the pathogenesis, signs and symptoms, current diagnostic tools like lung function tests and imaging, and management strategies for COPD including medications and rehabilitation. It concludes by mentioning new molecular drug targets that may help in COPD treatment.
Sickle-Cell-Anemia-Beyond-the-Basics.pdf
Sickle cell anemia is a genetic blood disorder that affects millions worldwide and causes red blood cells to become misshapen and cause blockages. It is inherited from both parents and is more common in people of African, Middle Eastern, Mediterranean, and South Asian descent. While there is no cure, early detection through newborn screening and ongoing management including medications, transfusions, or transplants can help prevent complications and improve quality of life for those with sickle cell anemia.
Plus de Pranavi Uppuluri (13)
MOLECULAR DOCKING IN DRUG DESIGN AND DEVELOPMENT BY PRANAVI linkedin.pptx
MOLECULAR DOCKING IN DRUG DESIGN AND DEVELOPMENT BY PRANAVI linkedin.pptx
Unraveling-Zoonotic-Diseases-on-World-Zoonoses-Day-2023.pptx
Unraveling-Zoonotic-Diseases-on-World-Zoonoses-Day-2023.pptx
Dernier
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
10 Benefits an EPCR Software should Bring to EMS Organizations
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Ketone bodies and metabolism-biochemistry
This slide consists of all the topics of ketone . This can be used for exam purpose for writing about Diabetic keto acidosis etc . Thank you
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Kosmoderma Academy Of Aesthetic Medicine
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
vonoprazan A novel drug for GERD presentation
Vonoprazan, a new potassium acid channel blocker used in the conditions of GERD and gastric ulcer, duodenal ulcer ....
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Dr. ZANAB FARHEEN FAYAZ ,MDS(ORTHODONTICS & DENTOFACIAL ORTHOPEDICS ).
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Dernier (20)
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
MS INFOGRAPHICS.pptx
- 1. SYMPTOMS’ Vertigo Depression Fatigue Sleep Disorders Muscle Spasm’s Pain Impaired speech Poor balance Numbness Anxiety Loss of vision Cognitive impairment Bladder and bowl dysfunction FDA APPROVED DRUGS’ Natalizumab Fingolimad Glatiromer acetate Interferon beta 1a Dimethyl fumarate mitoxantrone RISK FACTORS Gene Mutations Pathogens Heavy metal exposure Vitamin D deficiency DIAGNOSIS Signs and symptoms Radiographic finding (MRI, CT) Laboratory finding (CSF sp. Oligoclonal bands) LUBLIN CLASSIFICATION OF MS Clinically isolated syndrome(CIS) Relapsing remitting MS(RRMS) Primary progressive MS(PPMS) Secondary progressive MS(SPMS) Multiple sclerosis (MS) is the most common demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged MULTIPLE SCLEROSIS ¾ of MS patients are women PRIMARILY AFFECTED ORGANS Optic nerve Brain Spine EPIDEMIOLOGY Female to male sex distribution of nearly 3:1. MS typically presents in young adult (mean onset of age 20-30 years) French neurologist Jean Martin Charcot was the first person to recognize MS as a distinct disease in 1868 Causes : Unknown PRANAVI UPPULURI Globally more than 2.5 million people are affected There is no cure but treatment can help prevent relapse PRANAVI UPPULURI